K. Khunti

First name
K.
Last name
Khunti
Chang, K. C., Soljak, M., Lee, J. T., Woringer, M., Johnston, D., Khunti, K., et al. (2015). Coverage of a national cardiovascular risk assessment and management programme (NHS Health Check): Retrospective database study. Prev Med. http://doi.org/10.1016/j.ypmed.2015.05.022
View
de Lusignan, S., Liaw, S. T., Dedman, D., Khunti, K., Sadek, K., & Jones, S. (2015). An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR). J Innov Health Inform. http://doi.org/10.14236/jhi.v22i2.79
View
Chang, K. C., Lee, J. T., Vamos, E. P., Soljak, M., Johnston, D., Khunti, K., et al. (2016). Impact of the National Health Service Health Check on cardiovascular disease risk: a difference-in-differences matching analysis. Cmaj. http://doi.org/10.1503/cmaj.151201
View
Danese, M. D., Gleeson, M., Kutikova, L., Griffiths, R. I., Azough, A., Khunti, K., et al. (2016). Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK. BMJ Open. http://doi.org/10.1136/bmjopen-2016-011805
View
Khunti, K., Nikolajsen, A., Thorsted, B. L., Andersen, M., Davies, M. J., & Paul, S. K. (2016). Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes Obes Metab. http://doi.org/10.1111/dom.12626
View
Paul, S. K., Klein, K., Majeed, A., & Khunti, K. (2016). Association of smoking and concomitant metformin use with cardiovascular events and mortality in people newly diagnosed with type 2 diabetes. J Diabetes. http://doi.org/10.1111/1753-0407.12302
View
Danese, M. D., Gleeson, M., Kutikova, L., Griffiths, R. I., Khunti, K., Seshasai, S. R. K., & Ray, K. K. (2017). Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2016-013851
View
Kosiborod, M., Cavender, M. A., Fu, A. Z., Wilding, J. P., Khunti, K., Holl, R. W., et al. (2017). Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotranspo. Circulation. http://doi.org/10.1161/circulationaha.117.029190
View
Wilding, J. P. H., Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., et al. (2017). Changes in HbA1c and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice. Diabetologia.
View
Desai, U., . Y. Kirson, N., Kim, J., Khunti, K., King, S., Trieschman, E., et al. (2018). Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc17-0662
View